Overview
Pharmacists are key members of the oncology care team involved in ensuring patients with breast cancer understand the intricate dosing, sequencing, and adverse effect profiles of specialized regimens. The 2026 Breast Cancer Day of Education provides oncology pharmacists with evidence-based updates on the use of targeted therapies including CDK4/6 inhibitors, PARP inhibitors, and HER2-targeted agents. Join PTCE for a full day of expert-led, case-based discussions designed to support understanding of mutational testing, managing challenging adverse effects, and driving patient adherence in both early-stage and metastatic disease.
Activity Disclaimer
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Educational Disclaimer
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Pharmacy Times Office of Continuing Professional Education, LLC. | 2 Commerce Drive | Cranbury, NJ 08512
Privacy Policy | Terms & Conditions | Educational Disclaimer | Activity Disclaimer | Contact Us
© Pharmacy Times Office of Continuing Professional Education, LLC. 2026. All Rights Reserved